Travere Therapeutics (TVTX) Q2 2023 Earnings

3AugConfirmed
Oct 22
Q4 2022
Q1 2023
Q2 2023
-1.17
-1.03
-0.9
-0.76

Details

Expected EPS
-1.16
Actual EPS
-0.77
Surprise EPS
0.39
Surprise Percent
+33.62%

Description

Travere Therapeutics (TVTX) has reported earnings of -0.77 per share for Q2 2023.

0 Comments

Share your thoughts